LLDT-8: A Promising New Drug for Managing Immune Activation in HIV/SIV Infection
Chronic immune activation is a major challenge in treating HIV/SIV infection. This is because it can lead to a decline…
Chronic immune activation is a major challenge in treating HIV/SIV infection. This is because it can lead to a decline…